REPLIGEN Stock Price
$8.48 
Change:
0.04 0.24% Volume:
6,335
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 8.54 | Todays Low: 8.43 | Open: 8.44 | Last Close: 8.52
52 Wk High: 9.55 | 52 Wk Low: 3.73 | Todays Pivot: 8.48 | Pre market open: 5.92
Sector: 
Online News For Repligen
|
Repligen CEO to Present at Jefferies 2013 Global Healthcare Conference - NASDAQ (press release)
Thu, 23 May 2013 17:42WALTHAM, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present a corporate update at the Jefferies 2013 Global Healthcare ...
|
|
Repligen Stock Sees Short Interest Move 24.7% Higher - Forbes
Fri, 10 May 2013 19:35The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 659,013 share increase in total short interest for Repligen Corp. (NASD: RGEN), to 3,324,779, an increase of 24.72% since 04/15/2013.
|
|
REPLIGEN CORPORATION : Repligen Reports First Quarter 2013 Financial ... - 4-traders (press release)
Thu, 02 May 2013 19:41WALTHAM, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today reported financial results for the first quarter ended March 31, 2013. Below are financial and business highlights for the first quarter of 2013, financial ...
|
|
Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript - Seeking Alpha
Sat, 04 May 2013 04:05Good day, ladies and gentlemen, and welcome to the First Quarter 2013 Repligen Corporation Earnings Conference Call. My name is Clinton, and I will be your coordinator for today. There will be a question-and-answer session towards the company's – after ...
|
|
Semi-Annual Changes to the NASDAQ Biotechnology Index - Wall Street Journal (press release)
Mon, 13 May 2013 12:09... Inc. (Nasdaq:FURX); Hyperion Therapeutics, Inc. (Nasdaq:HPTX); NewLink Genetics Corporation (Nasdaq:NLNK); Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX); Repligen Corporation (Nasdaq:RGEN); Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP); ...
|
|
Stocks Hitting 52-Week Highs - Benzinga
Wed, 08 May 2013 14:10Repligen (NASDAQ: RGEN) shares reached a new 52-week high of $9.449. Repligen's trailing-twelve-month profit margin is 23.17%. Lancaster Colony (NASDAQ: LANC) shares gained 0.30% to reach a new 52-week high of $80.64. Lancaster Colony's ...
|
RGEN Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Repligen quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for RGEN to choose from. Visit here to build your stock quote widget »
